|
Subject: mixed treatment analysis clin.trial. Контекст:
Botulinum neurotoxin-A (BoNT-A) has become widely used in aesthetic applications over the past 20 years with several formulations now available. Although widely assumed to be equipotent, recent claims that the original commercial formulation, onabotulinumtoxinA (Botox [R] /Vistabel [R], Allergan UK, Marlow, UK) is more potent than incobotulinumtoxinA (Bocouture [R] /Xeomine [R], Merz Pharma, UK) have raised concerns that clinicians may be persuaded to increase doses to the potential detriment of their patients. To investigate this further, a review of the clinical evidence for the commercially available cosmetic formulations of BoNT-A was undertaken alongside a meta-analysis, carried out using mixed treatment analysis (MIA) methodology, of the available clinical data in the aesthetic setting.
Подскажите, пожалуйста, есть ли у этого оборота устоявшийся русскоязычный эквивалент?
|
